• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71992-01
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Purulent Discharge (1812); Unspecified Infection (1930); Pain (1994); Discomfort (2330)
Event Date 09/22/2020
Event Type  Injury  
Manufacturer Narrative
At this time, product has not yet been returned.An extended investigation has been performed for the reported complaint.There was no indication that the product did not meet specification.The reported complaint is related to skin irritation or an allergic reaction to the patch adhesive of the freestyle libre sensor.Dhrs (device history review) for the freestyle libre sensor and freestyle libre sensor kit were reviewed, and the dhrs showed the freestyle libre sensor and freestyle libre sensor kit passed all tests prior to release.Dose audit reports were reviewed and demonstrates the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.If the product is returned, a physical investigation will be performed and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
A caregiver reported the customer experienced a skin reaction at the site of the adc freestyle libre 2 sensor, with symptoms of pain, pus, and discomfort.The customer had contact with a healthcare professional, who prescribed sodium fusidate 2% (topical antibiotic) as treatment.There was no report of death or permanent injury associated with this event.
 
Manufacturer Narrative
Sensor 3mh002ayx6d was returned and investigated.Visual inspection has been performed on the returned sensor and no issues were observed on the sensor patch.The adhesive was not returned.An extended investigation has already been performed on the sensor and was previously submitted in the initial mdr.No malfunction or product deficiency was identified.All pertinent information available to abbott diabetes care has been submitted.Additional information section g1: (contact office first name, contact office last name, contact office phone number, and contact office email) have been updated.
 
Event Description
A caregiver reported the customer experienced a skin reaction at the site of the adc freestyle libre 2 sensor, with symptoms of pain, pus, and discomfort.The customer had contact with a healthcare professional, who prescribed sodium fusidate 2% (topical antibiotic) as treatment.There was no report of death or permanent injury associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 2
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
MDR Report Key10617382
MDR Text Key209539435
Report Number2954323-2020-06765
Device Sequence Number1
Product Code QLG
Combination Product (y/n)N
PMA/PMN Number
K193371
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 04/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/31/2021
Device Model Number71992-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/08/2021
Initial Date Manufacturer Received 09/25/2020
Initial Date FDA Received10/01/2020
Supplement Dates Manufacturer Received03/19/2021
Supplement Dates FDA Received04/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age7 YR
Patient Weight25
-
-